Skip to content

Drug interactions

Idelalisib + Tolterodine

Severity: Major

Idelalisib and Tolterodine: major interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Idelalisib is a strong CYP3A inhibitor and can substantially raise tolterodine concentrations. This increases anticholinergic adverse effects and QT risk.

What this interaction means in plain words

Idelalisib and Tolterodine can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Idelalisib belongs to Oncology; Tolterodine belongs to Genitourinary.

Evidence level: Moderate

Why it happens

Strong CYP3A4 inhibition reduces tolterodine clearance.

What to do

Limit tolterodine to a maximum of 2 mg daily, or use an alternative bladder antimuscarinic not dependent on CYP3A4. Monitor for anticholinergic toxicity.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Idelalisib and Tolterodine, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Idelalisib with Tolterodine?

MediHelp rates the interaction as major. Idelalisib and Tolterodine can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Idelalisib is a strong CYP3A inhibitor and can substantially raise tolterodine concentrations. This increases anticholinergic adverse effects and QT risk.

How serious is the interaction between Idelalisib and Tolterodine?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Limit tolterodine to a maximum of 2 mg daily, or use an alternative bladder antimuscarinic not dependent on CYP3A4. Monitor for anticholinergic toxicity.

What other medicines interact with Tolterodine?

MediHelp also lists interactions of Tolterodine with, for example, Clarithromycin, Clozapine, Cobicistat. The full list is on the Tolterodine page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in